CJC-1295 no DAC 5mg

 

CJC-1295 No DAC Peptide — Modified GRF 1-29 Research Compound

CJC-1295 No DAC is a synthetic peptide commonly identified in research literature and laboratory catalogs as Modified GRF 1-29 (Mod GRF 1-29). It is a modified analogue of growth hormone-releasing hormone (GHRH) and is primarily of interest in laboratory research involving GHRH receptor signaling, peptide characterization, and growth-hormone-related pathways.
Unlike the DAC-modified form of CJC-1295, the No DAC version does not contain the Drug Affinity Complex. This structural distinction gives the two compounds different analytical and pharmacokinetic characteristics, making accurate identification especially important when selecting a research reference material.

Our CJC-1295 No DAC peptide is supplied as a lyophilized research compound with product specifications and batch documentation intended to support laboratory identification, quality control, and analytical research.

For research use only. Not for human or veterinary use. Not intended for diagnostic, therapeutic, or dietary applications.

What Is CJC-1295 No DAC?

CJC-1295 No DAC is also known as CJC-1295 without DAC, Modified GRF 1-29, or Mod GRF 1-29. It is a synthetic 29-amino-acid analogue based on the first 29 amino acids of GHRH.
The molecule incorporates several amino-acid substitutions designed to alter its stability compared with native GHRH. Commercial research catalogs commonly describe the No DAC compound as a tetrasubstituted GHRH analogue.
A
AKH BioLabs
+1

The term “No DAC” is important because it distinguishes this material from CJC-1295 containing the Drug Affinity Complex. The DAC modification changes the molecular structure and substantially changes the compound’s behavior in research models.

For laboratories comparing GHRH analogues, the distinction between CJC-1295 No DAC and CJC-1295 DAC should therefore be maintained throughout purchasing, sample preparation, analytical testing, and data interpretation.

CJC-1295 No DAC vs. CJC-1295 DAC

Although the names are similar, CJC-1295 No DAC and CJC-1295 DAC should not be treated as interchangeable research materials.
CJC-1295 No DAC / Modified GRF 1-29 lacks the Drug Affinity Complex and is generally characterized as the shorter-duration form. CJC-1295 DAC incorporates an additional albumin-binding modification intended to extend exposure.

This difference is relevant to experimental design because researchers studying timing, receptor signaling, peptide stability, or comparative pharmacology may require one molecular form specifically rather than another.

When ordering a research peptide, laboratories should verify:

Exact compound name
No DAC versus DAC designation
Molecular formula
Molecular weight
Batch or lot number
Analytical purity
Identity confirmation
Certificate of Analysis (COA)
Physical presentation
Storage requirements
Clear documentation helps prevent confusion between closely related peptide products.
CJC-1295 No DAC Research Applications
CJC-1295 No DAC is used as a research material in investigations involving the GHRH receptor pathway and related biological signaling.
Potential laboratory research areas include:

GHRH receptor binding research
Peptide-receptor interaction studies
Growth-hormone signaling research
Pituitary and somatotroph research
Comparative GHRH analogue studies
Peptide stability investigations
Analytical method development
Chromatographic characterization
Mass-spectrometric identification
In-vitro research involving peptide signaling pathways
These applications describe areas of scientific investigation rather than established medical uses.
Researchers should also distinguish evidence concerning the No DAC molecule from studies involving other CJC-1295 formulations. Commercial research pages frequently note that the two forms have materially different characteristics.
B
BioCura Labs
+1

CJC-1295 No DAC Specifications

Typical catalog specifications for CJC-1295 No DAC include:
Product name: CJC-1295 No DAC
Alternative name: Modified GRF 1-29 / Mod GRF 1-29
Compound class: Synthetic GHRH analogue
Physical form: Lyophilized powder
Molecular formula: C152H252N44O42
Approximate molecular weight: 3367.9 g/mol
Research designation: Laboratory research use only

Reported specifications can vary by supplier, salt form, analytical method, and individual production batch. For this reason, researchers should rely on the documentation supplied with the specific lot rather than assuming that every CJC-1295 No DAC product has identical analytical characteristics. Current research catalogs report the formula and molecular weight in approximately this range.
P
proteuspeptides.com
+1

Quality Control and Certificate of Analysis

For research peptides, analytical documentation is an important part of responsible sourcing.
A Certificate of Analysis (COA) should allow the researcher to connect the analytical results to the specific production batch. Depending on the supplier and testing program, documentation may include analytical purity, identity confirmation, chromatographic data, mass-spectrometry results, and other quality-control information.

When evaluating a CJC-1295 No DAC supplier, researchers should look beyond a headline purity percentage and review the underlying documentation.

Important quality indicators include:

Lot-specific COA
HPLC or comparable chromatographic purity analysis
Mass-spectrometry identity confirmation
Clearly identified testing laboratory
Batch number matching the supplied material
Product quantity or assay information where applicable
Clearly stated storage conditions
Transparent product specifications
Some research suppliers currently advertise independent HPLC and mass-spectrometry testing for individual lots.

Why Buy CJC-1295 No DAC From a Research Peptide Supplier?

Selecting a research peptide supplier involves more than finding a product with the correct name.
Researchers need reliable identification, consistent documentation, appropriate packaging, and transparent quality-control information. A supplier specializing in laboratory research compounds should make it straightforward to verify what compound is being supplied and which analytical results correspond to the batch.

When comparing CJC-1295 No DAC peptide vendors, consider:

Lot-specific testing
Accessible COAs
Clear product nomenclature
Accurate molecular information
Transparent research-use labeling
Appropriate packaging
Documented storage recommendations
Responsive technical or product support
Clear ordering and shipping policies
A transparent documentation process can make it easier for laboratories to maintain internal records and reproduce analytical work.
CJC-1295 No DAC Peptide Storage
CJC-1295 No DAC is commonly supplied in lyophilized form. Research suppliers may recommend refrigerated or frozen storage depending on their formulation, packaging, and validated stability information.
Storage requirements should always follow the instructions supplied with the specific product and batch.

As a general laboratory quality-control principle, researchers should protect peptide materials from unnecessary exposure to heat, moisture, light, and repeated temperature fluctuations. Once a research material has been prepared for an experiment, stability should be considered separately from the stability of the original lyophilized material.

Do not assume that storage recommendations for one peptide formulation automatically apply to another.

Ordering CJC-1295 No DAC

Before purchasing CJC-1295 No DAC, verify that the product description specifically identifies the material as CJC-1295 without DAC / Modified GRF 1-29.
Because CJC-1295 DAC and No DAC can appear under similar commercial names, checking the molecular and analytical documentation is preferable to relying solely on the product title.

For institutional and laboratory purchasing, retain the product name, lot number, COA, invoice, and relevant technical documentation with your research records.

If your laboratory requires a particular quantity, analytical specification, or testing method, confirm those requirements with the supplier before placing an order.

Frequently Asked Questions

Is CJC-1295 No DAC the same as Modified GRF 1-29?
CJC-1295 No DAC is commonly marketed and cataloged as Modified GRF 1-29 (Mod GRF 1-29). Supplier terminology can vary, so researchers should verify the molecular specifications and COA for the material being purchased.
A
AKH BioLabs
+1
What does “No DAC” mean?

“No DAC” indicates that the peptide does not contain the Drug Affinity Complex associated with the DAC-modified form of CJC-1295. The distinction is chemically and experimentally relevant.
What is CJC-1295 No DAC used for?
It is supplied as a research compound for laboratory investigations involving GHRH-related signaling, receptor studies, peptide characterization, and related preclinical or in-vitro research.
Does CJC-1295 No DAC have FDA approval?
CJC-1295 No DAC should not be represented as an FDA-approved therapeutic product. The FDA has noted limited clinical data concerning CJC-1295 and identified safety and characterization concerns relating to compounded products containing CJC-1295.
U
U.S. Food and Drug Administration

Does CJC-1295 No DAC have the same properties as CJC-1295 DAC?
No. The No DAC and DAC forms have different molecular structures because the DAC modification is absent from the No DAC form. Consequently, they should be treated as distinct research materials.
Should I choose CJC-1295 No DAC or CJC-1295 DAC?
The appropriate research material depends on the experimental objective. Researchers studying the shorter-duration, non-DAC analogue should specifically source CJC-1295 No DAC / Modified GRF 1-29 rather than substituting the DAC form.
Is a Certificate of Analysis available?
A lot-specific COA is the preferred documentation for confirming the analytical characteristics of a research peptide. Availability and testing parameters depend on the supplier. When purchasing, request the COA corresponding to the exact lot supplied.
Research-Use-Only Statement
CJC-1295 No DAC is supplied strictly as a laboratory research compound. It is not intended for human consumption, veterinary use, self-administration, diagnosis, treatment, cure, mitigation, or prevention of any disease or medical condition.
No information on this page should be interpreted as a recommendation for human use, dosing, treatment, bodybuilding, weight management, anti-aging, or performance enhancement.

Researchers are responsible for ensuring that acquisition, handling, storage, testing, and use of the material comply with applicable laws, institutional requirements, laboratory procedures, and safety standards.

CJC-1295 No DAC — Research-Grade Peptide Documentation

For laboratories searching for CJC-1295 No DAC peptide, CJC-1295 without DAC, or Modified GRF 1-29, transparent product identification and batch documentation should be the priority.
Review the compound specification, verify the No DAC designation, examine the applicable COA, and maintain the relevant lot information with your research records.

CJC-1295 No DAC — Modified GRF 1-29 for laboratory research and analytical applications.

Research use only. Not for human or veterinary use.

This version deliberately targets the main commercial/search phrases—“CJC-1295 no DAC peptide,” “CJC-1295 without DAC,” “Modified GRF 1-29,” “COA,” “research peptide,” and “CJC-1295 vendor”—while keeping the claims defensible. Current vendor pages use the same core terminology and specifications, although individual vendors report different purity/testing details.
A
AKH BioLabs
+2

I can also turn this into a complete SEO landing page package with a title tag, meta description, URL slug, FAQ schema content, image alt text, internal-link anchors, and a keyword map.

U
A
B
Sources